Does anyone have a policy willing to share on the process outlined of when a TPN needs to be paused and disconnected from a Pediatric/Infant patient going to the OR? Thank you

Our organization is assessing all smart infusion pump vendors on the market for best fit from a workflow, alignment with ISMP best practice, user interface/experience, drug library functionality, & IT security perspective. We are also exploring interoperability within the next 2 - 3 years.

Has anyone undergone such an assessment in the last 2 - 3 years? Do you have a comparison of any of the vendors around those key points above. We are looking for a head to head comparison if you are willing to share? Something more tangible and concrete than what Klas has

Thanks

Hi all,

We have been navigating sterile water in patient care areas for the Paradise Ultrasound Renal Denervation (RDN) system, which was just featured in the ISMP Newsletter on August 22, 2024. This system includes tubing and an integrated spike that connects to a required sterile water supply (250mL, 500mL and 1000mL are FDA approved), which serves as a coolant. With the concern around sterile water in patient care areas, has anyone developed safe protocols for the stocking, storage, and monitoring of sterile water for injection for the RDN System?

Does any institution dispense medications for subcutaneous administration from the pharmacy to the nursing unit in syringes with needles attached? If so, do you have literature that supports this? We are trying to address some occurrences associated with wrong route administration, specifically with SQ routes and would like to standardize our practice across all of our satellite pharmacies to address this issue. All IV/SQ doses dispensed from our pharmacies that specialize in adult care are sent in luer-lock syringes without needles.

Good morning,

The Anesthesia Patient Safety Foundation is hosting the Stoelting Conference next week (9/4-9/5), with the theme of: "Transforming Anesthetic Care: A Deep Dive into Medication Errors and Opioid Safety."

The virtual portion of the conference is free and you can register here:
https://www.apsf.org/event/apsf-stoelting-conference-2024/

Have a safe holiday weekend!

--Stephen

Hello!

Would anyone be willing to share the order sets/policy/protocols for contrast? I am especially interested in the omnipaque given orally and contrast given by fluoroscopy.

Thank you in advance!

Helen Lee

Good morning,

we are revamping to decrease our patient own supplied medications used within the inpatient setting- wondering if anyone is prohibiting use ? And what specifically you are doing for OBS patients ?

thanks
Laura

Currently, we are using Hospira’s brand of Heparin 25,000 units/250mL (NDC # 0409-4520-02) for our continuous Heparin infusions. Nursing is having difficulty scanning the product and have requested additional labels with a readable barcode. We are reluctant to do this for fear of proxy scanning. Has anyone else ran into this problem? And if so, how did you improve your Heparin drip scanning rate? Any suggestions outside of extra labels would be appreciated. THANK YOU ALL.

Hello!
My organization has been developing a downtime plan for providing parenteral nutrition (TPN, PN) during an electronic health record (EHR) unplanned downtime event. Currently, PN is provided using custom internally compounded PN (using Baxter Exactamix) and using commercially available premixed solutions (e.g., Clinimix, PeriOlimel, Olimel, SmofKabiven, SmofKabiven Peripheral).

Have any facilities experienced precipitation with pantoprazole for injection after reconstituting per the package insert? If yes, can you share the NDC(s) this occurred with, how frequently, and if this led you to change your preferred formulation?